CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD 
Evotec and Bristol Myers Squibb Extend and Expand Strategic Partnership
HAMBURG, GERMANY / ACCESSWIRE / May 10, 2022 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE 000 566480...
Evotec and Bristol Myers Squibb Extend and Expand Strategic Partnership in Protein Degradation
8-YEAR EXTENSION AND EXPANSION OF COLLABORATION TO DEVELOP PIPELINE OF MOLECULAR GLUE DEGRADERSCOLLABORATION LEVERAGES EVOTEC'S PROPRIETARY EVO PANOMICS AND EVO...
NY Cannabis Insider In-Person, Professional Conference May 20th in Albany
Event features industry thought leaders, panel discussions, lightning-round consultations, professional headshots, networking opportunities and a vendor fairALBANY, NY / ACCESSWIRE...
Stereotaxis Reports 2022 First Quarter Financial Results
ST. LOUIS, May 10, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for...
Taconic Biosciences Appoints Nomura Siam as Distributor in India for All Taconic Animal Models
Improves Access to Critical Rodent Models for Researchers in IndiaRENSSELAER, N.Y., May 10, 2022 (GLOBE NEWSWIRE) -- Taconic Biosciences, a...
Alpha Pro Tech, Ltd. Announces First Quarter 2022 Financial Results
Building Supply Segment Sales Increased 22.7% to a record $10.2 MillionNet sales for the first quarter of 2022 were $17.7...
Faculty Opinions Makes the Insights and Article Recommendations from its Global Network of Life Sciences and Medical Experts Free-to-access
Faculty Opinions, an H1 community, opens up its content by providing free access to 235,000+ research article recommendations in its...
Revolutionary eSight 4 Vision Assistance Device to be Showcased at Retina World Congress
Optical enhancement company attends conference with eSight 4 user to demonstrate the technology and discuss the future of vision techFORT...
Syneos Health Leaders Recognized by HBA
Healthcare Businesswomen’s Association Spotlights Kasey Boynton and Feni Komline for Biopharma Industry ImpactMORRISVILLE, N.C., May 10, 2022 (GLOBE NEWSWIRE) --...
Reverence Emerges from Stealth, Introduces Digital Health Platform to Operationalize Clinically Effective Home-Based Care at Scale
The company launches with $9.5M in initial funding led by Target GlobalNEW YORK, May 10, 2022 (GLOBE NEWSWIRE) -- Reverence,...
XIL Health Named to Inc. Magazine’s 2022 Best Workplaces List
The women-led healthtech company is recognized for its culture that focuses on the mental, emotional, physical and financial well-being of...
AXIM Biotechnologies Develops Novel Tear Sample Collector System, Files Patent Application
SAN DIEGO, May 10, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an...
Coherus BioSciences Management to Present at Upcoming Investor Conferences
REDWOOD CITY, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), announced today that senior management will...
Outlook Therapeutics to Participate in Retina World Congress 2022
ISELIN, N.J., May 10, 2022 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a pre-commercial biopharmaceutical company working to develop...
NeuroStar® Advanced Therapy for Mental Health Receives FDA Clearance for Treatment of Obsessive-Compulsive Disorder
Clearance allows for more access to non-drug, noninvasive treatment for patients suffering from MDD or OCDMALVERN, Pa., May 10, 2022...
EDAP TMS SA to Announce First Quarter 2022 Financial Results on May 17, 2022
Company to host conference call and webcast on, Wednesday, May 18that 8:30 am EDT LYON, France, May 10, 2022 -...
Alaunos Therapeutics to Present at the H.C. Wainwright Global Investment Conference
HOUSTON, May 10, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a clinical-stage oncology-focused cell...
Turning Point Therapeutics Granted Breakthrough Therapy Designation for Repotrectinib Treatment in Patients With One Prior ROS1 Tyrosine Kinase Inhibitor and no Prior Chemotherapy
SAN DIEGO, May 10, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a clinical-stage precision oncology company designing...
Wave Life Sciences to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed...
Celsion Corporation Highlights Pipeline Progress in Its Lead Development Candidates
PLACCINE DNA-based Vaccine in proof-of-concept non-Human Primate Studies Phase II study of GEN-1 in ovarian cancer 85% enrolled with full...